Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 80 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

1%

1 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed trials have results

Key Signals

29 recruiting3 with results

Enrollment Performance

Analytics

N/A
29(70.7%)
Phase 1
5(12.2%)
Phase 2
3(7.3%)
Early Phase 1
3(7.3%)
Phase 3
1(2.4%)
41Total
N/A(29)
Phase 1(5)
Phase 2(3)
Early Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (80)

Showing 20 of 80 trials
NCT07558629Active Not Recruiting

SH-SDU Shandong Endometriosis Reproductive Cohort

Role: lead

NCT07495111Not ApplicableRecruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Role: collaborator

NCT05998902Phase 3Recruiting

Optimizing Early Nutrition Support in Severe Stroke-2

Role: collaborator

NCT06554301Phase 1Recruiting

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

Role: collaborator

NCT07267884Not ApplicableNot Yet Recruiting

IABP for MI-VSD Patients in SCAI SHOCK Stage B

Role: collaborator

NCT07430579Not ApplicableRecruiting

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Role: lead

NCT07413068Recruiting

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Role: collaborator

NCT04217239Not ApplicableCompleted

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Role: lead

NCT07379281Recruiting

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Role: collaborator

NCT07379268Recruiting

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT07379255Recruiting

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT03736707Not ApplicableRecruiting

High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial

Role: collaborator

NCT06604091Active Not Recruiting

Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)

Role: lead

NCT07129499Not ApplicableNot Yet Recruiting

Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas

Role: collaborator

NCT07123116Not ApplicableNot Yet Recruiting

Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas

Role: collaborator

NCT06991530Completed

Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure

Role: lead

NCT06461234Recruiting

Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction

Role: collaborator

NCT05141435Not ApplicableCompleted

NHFOV as Primary Support in Very Preterm Infants With RDS

Role: collaborator

NCT03591796Not ApplicableCompleted

Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)

Role: collaborator

NCT06170749Completed

Prediction Model for Anemia After Bariatric Surgery

Role: collaborator